FDA Warns Montana Compounder Over Insanitary Conditions

Drug Industry Daily
A A
The FDA issued a warning letter to a Montana compounding pharmacy for insanitary conditions and significant violations of good manufacturing practices.

To View This Article:

Login

Subscribe To Drug Industry Daily